Table 4 Coefficients of determination (R2) and residual correlations (ρ) by section of the selected path analysis model (via stepwise regression)
Inflammation markers (first level mediators) | Red Blood markers (second level mediators) | Outcomes | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
CRP | ROS | Slope | Lag-time | RDW | MCV | Insulin | HOMA | HDL | BGL | ||
Inflammationmarkers (first level mediators) | CRP | 0.108 (P = 0.027) | 0.097 (P = 0.294) | 0.160 (P = 0.033) | −0.020 (P = 0.708) | – | – | – | – | – | – |
ROS | 0.018 (P < 0.001) | – | – | – | – | – | – | – | – | ||
Slope | 0.059 (P < 0.001) | −0.233 (P = 0.013) | – | – | – | – | – | – | |||
Lag-time | 0.213 (P < 0.001) | – | – | – | – | – | – | ||||
Red Blood-markers (second level mediators) | RDW | 0.252 (P < 0.001) | 0.000 (P = 0.998) | – | – | – | – | ||||
MCV | 0.042 (P < 0.001) | – | – | – | – | ||||||
Outcomes | Insulin | 0.029 (P < 0.001) | 0.981 (P < 0.001) | −0.171 (P = 0.040) | 0.021 (P = 0.629) | ||||||
HOMA | 0.032 (P < 0.001) | −0.157 (P = 0.055) | 0.141 (P = 0.003) | ||||||||
HDL | 0.052 (P < 0.001) | 0.104 (P = 0.293) | |||||||||
BGL | 0.009 (P = 0.107) | ||||||||||